Surrozen Operating Inc. Secures Anti-Frizzled Antibody Patent
Summary
The USPTO granted Patent US12606629B2 to Surrozen Operating, Inc. on April 21, 2026. The patent covers monospecific anti-Frizzled monoclonal antibodies and related compositions for therapeutic applications. The application, filed July 2, 2020, received 10 claims under CPC classifications including C07K 16/2863.
What changed
The USPTO granted Surrozen Operating, Inc. a patent for monospecific anti-Frizzled monoclonal antibodies and their use in therapeutic methods for disease treatment. The patent covers the antibodies themselves and methods of treatment using them.
For competitors in the Wnt/Frizzled signaling pathway space, this grant establishes IP protection around a specific antibody class. While the patent does not impose compliance obligations on third parties, firms developing similar anti-Fzd therapeutics should review this IP landscape to assess freedom-to-operate considerations.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Monospecific anti-frizzled antibodies and methods of use
Grant US12606629B2 Kind: B2 Apr 21, 2026
Assignee
Surrozen Operating, Inc.
Inventors
Yang Li, Thomas Steven Lopez, I-Chieh Wang, Parthasarathy Sampathkumar
Abstract
The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
CPC Classifications
C07K 16/2863 C07K 16/28 C07K 2317/31 C07K 2317/33 C07K 2317/52 C07K 2317/55 C07K 2317/569 C07K 2317/64 C07K 2317/71 C07K 2317/75 C07K 2299/00 C07K 2317/92 C07K 2319/00 A61K 38/00
Filing Date
2020-07-02
Application No.
17623006
Claims
10
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.